News
PharMEDium Elects William R. Spalding to Board of Directors
August 25, 2010 7:32 am | by Bio-Medicine.Org | CommentsLAKE FOREST, Ill., Aug. 25 /- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the election of William R. Spalding to the company's Board of Directors. Spalding is Co-founder and Principal of The Crawford Spalding Group, an advisory and management services...
Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
August 25, 2010 7:32 am | by Bio-Medicine.Org | CommentsMindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and... -- SHENZHEN, China, Aug. 25 /PRNewswire-Asia-FirstCall/ --
Kewaunee Scientific Corporation Declares Quarterly Dividend
August 25, 2010 7:32 am | by Bio-Medicine.Org | CommentsSTATESVILLE, N.C., Aug. 25 /- Kewaunee Scientific Corporation (Nasdaq: KEQU ) announced today that its Board of Directors declared a quarterly cash dividend of ten cents per outstanding share, payable on September 23, 2010 to stockholders of record at the close of business on September 9,...
Physician Referrals Limiting Treatment of the Venous System
August 25, 2010 7:32 am | by Bio-Medicine.Org | CommentsTORONTO, Aug. 25 /- Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that although venous procedures are set to grow by more than 10% through 2013, a lack of awareness among referring physicians is a major roadblock in increased...
Veteran Affairs Announces That Redsense Alarm Will be Mandatory on Patients by November 1, 2010
August 25, 2010 7:32 am | by Bio-Medicine.Org | CommentsVeteran Affairs Announces That Redsense Alarm Will be Mandatory on... -- HALMSTAD, Sweden and CHICAGO, August 25, 2010 /-
DynaMatrixâ„¢ to be Featured on Discovery Channel Segment Highlighting Innovative Products in Oral Health
August 25, 2010 7:32 am | by Bio-Medicine.Org | CommentsBURLINGTON, Mass., Aug. 25 /- Keystone Dental, an oral healthcare company focused on restoring smiles, today announced that DynaMatrix â„¢ Extracellular Membrane, the company's soft tissue regeneration product, will be featured on an upcoming episode of Health Heroes on the Discovery...
Reportlinker Adds Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016
August 25, 2010 7:31 am | by Bio-Medicine.Org | CommentsNEW YORK, Aug. 25 /- Reportlinker.com announces that a new market research report is available in its catalogue: Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016...
Reportlinker Adds Clinical Laboratory Testing Volume 1: Reagents and Instruments
August 25, 2010 7:31 am | by Bio-Medicine.Org | CommentsNEW YORK, Aug. 25 /- Reportlinker.com announces that a new market research report is available in its catalogue: Clinical Laboratory Testing Volume 1: Reagents and Instruments http://www.reportlinker.com/p0284247/Clinical-Laboratory-Testing-Volume-... Clinical...
NKT Therapeutics taps backers for $4M in new round
August 25, 2010 6:32 am | by Mass High Tech: The Journal of New England Technology | CommentsNewton biotech NKT Therapeutics Inc. has closed on $4 million in a new round of funding, according to federal documents. That brings the company's total institutional backing to $12 million since it was founded in 2008.
Federal Register: Effective Date of Requirement for Premarket Approval for Four Class III Preamendments Devices
August 25, 2010 5:33 am | by U.S. Food & Drug Administration | CommentsThe FDA is proposing to require the filing of a PMA or a PDP for the following four class III preamendments devices: Ventricular bypass (assist) device; pacemaker repair or replacement material; female condom; and transilluminator for breast evaluation.
Embryonic Stem Cell Research in the Toilet, According to Arthritis Treatment Center
August 25, 2010 4:33 am | by Bio-Medicine.Org | CommentsFREDERICK, Md., Aug. 25 /- The recent ruling by federal judge Royce C. Lamberth halting embryonic stem cell research may present a hurdle for some disease research but not necessarily for arthritis. Â A key note presentation, entitled " Guided Mesenchymal Stem Cell Layering Technique...
Jennerex Appoints Lara Longpre to Chief Operating Officer
August 25, 2010 4:32 am | by Bio-Medicine.Org | CommentsSAN FRANCISCO, Aug. 25 /- Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced the appointment of Lara Longpre to the position of chief operating officer. Ms. Longpre will be responsible for the development of the company's lead product, JX-594, as well as...
KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology
August 25, 2010 4:32 am | by Bio-Medicine.Org | CommentsNORTH LIBERTY, Iowa, Aug. 25 /- KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the...
BridgeHead Software Reveals: & #8216;Why Disaster Recovery Is Different In Healthcare & #8217;
August 25, 2010 2:32 am | by RealWire | CommentsFree whitepaper explains that an effective Healthcare Disaster Recovery strategy is dependent on a solid understanding of a hospital's applications and dataAshtead, UK and Woburn, MA, USA - August 25, 2010 - BridgeHead Software today released a whitepaper on Healthcare Disaster Recovery...
Mayo researchers develop new laboratory cell lines to study treatment for ATC
August 24, 2010 9:31 pm | by EurekAlert | Comments(Mayo Clinic) To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer they were using to help them find new treatments for this lethal disease were probably some other kind of cancer.
